Multiple sclerosis: Relapses and timing of remissions

被引:10
作者
Iuliano, Gerardo [1 ]
Napoletano, Rosa [1 ]
Esposito, Antonio [1 ]
机构
[1] Osped Riuniti Salerno, Ctr Provinciale Sclerosi Multipla, Azienda Osped, UO Neurol, Salerno, Italy
关键词
relapsing-remitting multiple sclerosis; expanded disability status scale; timing of remissions;
D O I
10.1159/000109260
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Relapse is a relatively sudden worsening of neurological status in multiple sclerosis patients. The aim of this paper is to describe the frequency and timing of the subsequent clinical remission, and factors linked to a possible lack of recovery. Methods: Two hundred and twenty-three relapses in 62 multiple sclerosis patients were examined retrospectively. Kurtzke's Expanded Disability Status Scale (EDSS) scores were calculated every 3 months from 1 year before to 1 year after. Remission was defined as improvement vs. the EDSS as scored during the relapse. Recovery was defined as return to the EDSS as scored before the relapse. Results: The frequency of improvement was 78% at 3 months, 86% at 6, and lower in males (65 vs. 81%). The frequency of recovery was 55% at 3 months, 71% at 6. Kaplan-Meier curves showed stabilization after 6 months, with improvement in 90% of patients, 100% without further relapses. Relapses without recovery were only 30%; 15% excluding short-term relapses. Conclusions: Incomplete remissions do not appear to be linked to the evolution of the relapse, but to further relapses in the following months; in other words, to the short-term relapse rate. Copyright (C) 2007 S. Karger AG, Basel.
引用
收藏
页码:44 / 48
页数:5
相关论文
共 12 条
[1]
ACHITII GJ, 2001, MED THER, V7, P13
[2]
*AG NAT ACCR, 2001, EV SANT FED FRANC NE
[3]
Relapses and progression of disability in multiple sclerosis. [J].
Confavreux, C ;
Vukusic, S ;
Moreau, T ;
Adeleine, P .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (20) :1430-1438
[4]
Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process [J].
Confavreux, C ;
Vukusic, S ;
Adeleine, P .
BRAIN, 2003, 126 :770-782
[5]
GOODIN DS, 2002, DIS MODIFYING THERAP
[6]
Interferon β therapy for multiple sclerosis [J].
Goodkin, DE .
LANCET, 1998, 352 (9139) :1486-1487
[7]
THE DISABILITY STATUS SCALE FOR MULTIPLE-SCLEROSIS - APOLOGIA PRO DSS SUA [J].
KURTZKE, JF .
NEUROLOGY, 1989, 39 (02) :291-302
[8]
KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444
[9]
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis [J].
McDonald, WI ;
Compston, A ;
Edan, G ;
Goodkin, D ;
Hartung, HP ;
Lublin, FD ;
McFarland, HF ;
Paty, DW ;
Polman, CH ;
Reingold, SC ;
Sandberg-Wollheim, M ;
Sibley, W ;
Thompson, AJ ;
van den Noort, S ;
Weinshenker, BY ;
Wolinsky, JS .
ANNALS OF NEUROLOGY, 2001, 50 (01) :121-127
[10]
Assessment of different treatment failure criteria in a cohort of relapsing-remitting multiple sclerosis patients treated with interferon β:: Implications for clinical trials [J].
Río, J ;
Nos, C ;
Tintoré, M ;
Borrás, C ;
Galán, I ;
Combella, M ;
Montalban, X .
ANNALS OF NEUROLOGY, 2002, 52 (04) :400-406